temporary dissociativehallucinatory effects
Feb 13, 2019
The antidepressant drug gets support from FDA
The hallucinogenic party drug, ketamine has passed the final problem for going into the clinical stage as an antidepressant. The US Food and Drug Administration (FDA), an independent advisory committee, supported in favour of commending a compound known as esketamine, used for treating depression. If the FDA giv...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
